Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Balsano

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
The Journal of Biological Chemistry|September 22, 1995
Reactive oxygen intermediates mediate angiotensin II-induced c-Jun.c-Fos heterodimer DNA binding activity and proliferative hypertrophic responses in myogenic cellsP L Puri, M L Avantaggiati, V L Burgio, et al.
The Journal of Infectious Diseases|January 1, 1992
A second-generation hepatitis C virus confirmatory test for chronic hepatitis B virus infectionG Taliani, R Lecce, M C Badolato, et al.
Annals of the New York Academy of Sciences|March 27, 1995
Reactive oxygen intermediates (ROIs) are involved in the intracellular transduction of angiotensin II signal in C2C12 cellsP L Puri, M L Avantaggiati, V L Burgio, et al.
Archives of Virology. Supplementum|January 1, 1992
Recombinant immunoblot assay for hepatitis C virus antibody in chronic hepatitisG Taliani, M C Badolato, R Lecce, et al.
Oncogene|March 13, 1997
MyoD prevents cyclinA/cdk2 containing E2F complexes formation in terminally differentiated myocytesP L Puri, C Balsano, V L Burgio, et al.
Hepatology (Baltimore, Md.)|January 1, 1991
Significance of anti-HBx antibodies in hepatitis B virus infectionM Levrero, M Stemler, C Pasquinelli, et al.
International Journal of Tissue Reactions|January 1, 1993
Normalization of depressed natural killer activity after interferon-alpha therapy is associated with a low frequency of relapse in patients with chronic hepatitis CM S Bonavita, A Franco, M Paroli, et al.
Journal of Hepatology|January 1, 1991
Antibodies to hepatitis C virus in patients with hepatocellular carcinomaM Levrero, A Tagger, C Balsano, et al.
Journal of Hepatology|August 1, 1996
Elevated serum levels of 90K/MAC-2 BP predict unresponsiveness to alpha-interferon therapy in chronic HCV hepatitis patientsM Artini, C Natoli, N Tinari, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1994
Selective expansion of cytotoxic T lymphocytes with a CD4+CD56+ surface phenotype and a T helper type 1 profile of cytokine secretion in the liver of patients chronically infected with Hepatitis B virusV Barnaba, A Franco, M Paroli, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
The Journal of Biological Chemistry|September 22, 1995
Reactive oxygen intermediates mediate angiotensin II-induced c-Jun.c-Fos heterodimer DNA binding activity and proliferative hypertrophic responses in myogenic cellsP L Puri, M L Avantaggiati, V L Burgio, et al.
The Journal of Infectious Diseases|January 1, 1992
A second-generation hepatitis C virus confirmatory test for chronic hepatitis B virus infectionG Taliani, R Lecce, M C Badolato, et al.
Annals of the New York Academy of Sciences|March 27, 1995
Reactive oxygen intermediates (ROIs) are involved in the intracellular transduction of angiotensin II signal in C2C12 cellsP L Puri, M L Avantaggiati, V L Burgio, et al.
Archives of Virology. Supplementum|January 1, 1992
Recombinant immunoblot assay for hepatitis C virus antibody in chronic hepatitisG Taliani, M C Badolato, R Lecce, et al.
Oncogene|March 13, 1997
MyoD prevents cyclinA/cdk2 containing E2F complexes formation in terminally differentiated myocytesP L Puri, C Balsano, V L Burgio, et al.
Hepatology (Baltimore, Md.)|January 1, 1991
Significance of anti-HBx antibodies in hepatitis B virus infectionM Levrero, M Stemler, C Pasquinelli, et al.
International Journal of Tissue Reactions|January 1, 1993
Normalization of depressed natural killer activity after interferon-alpha therapy is associated with a low frequency of relapse in patients with chronic hepatitis CM S Bonavita, A Franco, M Paroli, et al.
Journal of Hepatology|January 1, 1991
Antibodies to hepatitis C virus in patients with hepatocellular carcinomaM Levrero, A Tagger, C Balsano, et al.
Journal of Hepatology|August 1, 1996
Elevated serum levels of 90K/MAC-2 BP predict unresponsiveness to alpha-interferon therapy in chronic HCV hepatitis patientsM Artini, C Natoli, N Tinari, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1994
Selective expansion of cytotoxic T lymphocytes with a CD4+CD56+ surface phenotype and a T helper type 1 profile of cytokine secretion in the liver of patients chronically infected with Hepatitis B virusV Barnaba, A Franco, M Paroli, et al.
Pageof 6